Iijima Takayoshi, Obata Soichiro, Miyagi Etsuko, Aoki Shigeru
Perinatal Center for Maternity and Neonate, Yokohama City University Medical Center, Yokohama, JPN.
Department of Obstetrics and Gynecology, Yokohama City University Hospital, Yokohama, JPN.
Cureus. 2023 Dec 29;15(12):e51275. doi: 10.7759/cureus.51275. eCollection 2023 Dec.
This study aimed to clarify the perinatal prognosis of preeclampsia (PE) with fetal growth restriction (FGR) and determine appropriate medical interventions for these conditions.
Singleton births delivered to mothers diagnosed with PE with FGR and hypertension at a tertiary center between January 2010 and June 2021 were included. Only patients with PE were included in the analysis, and patients with superimposed PE were excluded. The FGR-preceding group (group F) included patients who developed FGR first and had elevated blood pressure. The remaining cases were defined as the hypertension-preceding group (group H). The perinatal outcomes between the two groups were then compared. The primary outcome was pregnancy prolongation defined as the time from PE diagnosis to delivery. Secondary outcomes included mode of delivery, maternal outcomes, and neonatal outcomes.
The mean gestational age at the time of PE diagnosis was 34.7 (26-40.1) weeks for group F and 30.3 (22.6-39.4) weeks for group H (P=0.004). The median pregnancy prolongation from the time of PE diagnosis to delivery was eight (2-30) days in group F and 10.5 (2-43) days in group H, with no significant difference (P=0.52). The incidence of maternal critical complications was 10.4% in group F and 28.1% in group H (P=0.03; odds ratio 3.36; 95% confidence interval 1.13-10).
Among patients with PE, group H was more likely to develop serious maternal complications than group F, suggesting different pathogenesis between these types of PE. Both groups required cautious perinatal management, but more stringent maternal management was required for group H.
本研究旨在阐明合并胎儿生长受限(FGR)的子痫前期(PE)的围产期预后,并确定针对这些情况的适当医学干预措施。
纳入2010年1月至2021年6月在一家三级中心分娩的单胎新生儿,其母亲被诊断为合并FGR和高血压的PE。分析仅纳入PE患者,排除合并其他疾病的PE患者。FGR先出现组(F组)包括先出现FGR且血压升高的患者。其余病例定义为高血压先出现组(H组)。然后比较两组的围产期结局。主要结局是妊娠延长,定义为从PE诊断到分娩的时间。次要结局包括分娩方式、母亲结局和新生儿结局。
F组PE诊断时的平均孕周为34.7(26 - 40.1)周,H组为30.3(22.6 - 39.4)周(P = 0.004)。从PE诊断到分娩的妊娠延长中位数在F组为8(2 - 30)天,在H组为10.5(2 - 43)天,差异无统计学意义(P = 0.52)。F组母亲严重并发症的发生率为10.4%,H组为28.1%(P = 0.03;比值比3.36;95%置信区间1.13 - 10)。
在PE患者中,H组比F组更易发生严重的母亲并发症,提示这些类型的PE之间发病机制不同。两组均需要谨慎的围产期管理,但H组需要更严格的母亲管理。